Sort by
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
84%
Randomized Controlled Trial
72%
Bronchiectasis
56%
microRNA
46%
Lung Cancer
40%
Lung
33%
Pediatrics
31%
Chronic Cough
29%
Silo-Filler's Disease
28%
Quality of Life
28%
Diseases
28%
Coughing
25%
Pathogen
25%
Microbiome
24%
Respiratory Tract Infection
22%
Azithromycin
20%
DRESS Syndrome
20%
Real-Time Polymerase Chain Reaction
20%
Breathing
20%
Mucolytic Agent
20%
Extracellular Fluid
20%
Haemophilus influenzae
18%
Biological Marker
17%
Sputum
17%
Arm
15%
Table Salt
12%
Placebo
12%
Conjugate Vaccine
11%
Cystic Fibrosis
11%
Bronchitis
10%
Adverse Event
10%
Respiratory Disease
9%
Oral
9%
Ultrafiltration
8%
Forced Vital Capacity
7%
Forced Expiratory Volume
7%
Gene Sequence
7%
RNA 16S
7%
Mucolytic Agent
7%
Chronic Inflammation
6%
Respiratory Tract Inflammation
6%
Clinical Management
5%
Pneumococcus Vaccine
5%
Size-Exclusion Chromatography
5%
Pleural Disease
5%
Copurification
5%
Primary Outcome
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Lung Disease
54%
microRNA
46%
Lung Cancer
44%
Mucolytic Agent
40%
Randomized Controlled Trial
32%
Chronic Cough
22%
Erdosteine
22%
Coughing
22%
Disease Exacerbation
22%
Bronchiectasis
22%
Volatile Organic Compound
20%
Ciliary Dyskinesia
20%
DRESS Syndrome
20%
Electronic Cigarette
20%
Azithromycin
20%
Disease Severity
20%
Biological Marker
19%
Adverse Event
17%
Cigarette Smoke
16%
Diseases
15%
Table Salt
12%
Bronchitis
10%
Cytotoxicity
8%
Inflammation
8%
Mucolytic Agent
7%
Cystic Fibrosis
7%
Respiratory Tract Disease
6%
Observational Study
6%
Chronic Inflammation
6%
Biochemistry, Genetics and Molecular Biology
MicroRNA
30%
Blood Plasma
20%
Epidermal Growth Factor Receptor
20%
Infectious Agent
20%
Mediator
20%
Carcinogenesis
20%
Genomics
20%
Real-Time Polymerase Chain Reaction
20%
Proteinase Inhibition
20%
Serine Protease
20%
Forced Expiratory Volume
20%
Airflow
13%
DNA RNA Hybridization
10%
Metabolite
10%
Microvesicles
10%
Cell Communication
10%
16S Ribosomal RNA
7%
Gene Sequence
7%